Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
Anyone with asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
22 September 2018
The NHS should switch to electric vehicles across its organisations, health officials have advised.
[more...]
21 September 2018
UK holidaymakers could be missing out on more than 60 direct flight routes thanks to Air Passenger Duty (APD), a report suggests.
20 September 2018
Living in areas with high levels of air pollution could be linked to an increased risk of dementia, new research suggests.
19 September 2018
Multiple sclerosis (MS) patients are shelling out tens of thousands of pounds for care - and many are unable to cover the costs, a leading charity has warned.
18 September 2018
As much as £6 of every £10 spent on domestic flights in the UK goes on Air Passenger Duty (APD), new research suggests.
15 September 2018
UK driving licences might become invalid in certain European countries if the UK crashes out of the EU with no deal, the Government has warned.
14 September 2018
Online crowdfunding for cancer treatments is indirectly advancing the rise of alternative "quack" therapies, experts have warned.
13 September 2018
A "wee-stick" like those used in pregnancy testing could be employed to prevent thousands of deaths from ovarian cancer.
11 September 2018
As many as 1.3 million passengers endured severe flight delays in the last year, a new study reveals.
08 September 2018
British Airways customers are cancelling their credit cards after the carrier was hit by a 15-day data breach that compromised the details of around 380,000 people.
06 September 2018
Plastic trays at security desks harbour the highest numbers of viruses at airports, new research has discovered.
05 September 2018
Adults are being urged to take advantage of a new online tool to find out if they are at risk of having a heart attack or stroke.